Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


October 5-7, 2016
Boston Convention and Exhibition Center,
Boston, MA

The most complete event to successfully blueprint cell, gene, and immunotherapies from proof of concept to commercialization

Join the unique event that brings together 300+ key industry and academic luminaries to collectively discuss strategies and share lessons learned resulting from their latest research data and case studies.

Accelerate Your Cell and Gene-Based products towards commercial success

Navigate the Pathway to Commercialization

Gain insights from 80+ global thought-leading speakers on how overcome today’s challenges involving scale-up, facility design, characterization, tech transfer, regulatory approval, investment, reimbursement and more. New in-depth content added includes:

  • Gene Therapy
  • Immuno-Oncology
  • Regulatory Concerns
Ensure a Successful Product-to-Market Launch

Evaluate leading technologies by meeting face-to-face with 25+ international CMOs, CROs and who can accelerate your product towards commercial success.

Meet the Right Partners to Grow Your Business

Connect with 300+ thought-leaders and service providers who can offer the strategic, technical and financial support to ensure a success cell-based product launch.

Scientific Poster Hall

Highlight your company's latest research findings by presenting a scientific poster.

The initial poster submission deadline has passed. However, we are still accepting posters pending available space. Please submit your abstract at the link below and you will receive a confirmation once it is reviewed and approved for presentation.

Get Your $299 Biotech Week Boston Exhibit Hall Pass

Register for the Biotech Week Boston (BWB) 3-Day Exhibit Hall pass for $299.  This pass grants you access to Boston’s largest life science destination where you will partner, socialize and learn about the latest innovative technologies, and includes:

  • 3 BWB Keynotes including Steve Wozniak, Co-Founder, Apple Computer Inc. and Toni Hoover, Ph.D., Bill and Melinda Gates Foundation
  • Access to 200+ Exhibitors, Service Providers, and Technologies
  • Review the latest science research from 125+ Scientific Posters
  • 20+ Tech Workshops and Panel Discussions, including the Innovation Summit, in the BWB Theatre
  • And More...

What Makes This Event Unique

Six Focused Tracks

Keep your team up to date on the latest science, technologies and industry updates across the entire spectrum of cell therapy, gene therapy, and immuno-oncology product development:

  • NEW! Regulatory Considerations
  • NEW! Immuno-Oncology
  • NEW! Gene Therapy Development & Production
  • Cell Therapy Bioprocessing
  • Tools & Technologies
  • Commercialization
Content For All Company Types

This year’s event presents a complete blueprint from bench to commercial scale that’s accessible for any sized company, including:

  • Mid-Sized Gene and Cell Therapy Companies
  • Biotech Start-Ups 
  • Virtual Companies
  • Large Pharma and Biotechs
  • Academic Institutions
Why People Come Back

"The go-to conference for everything related to Cell Therapy Bioprocessing and Commercialization.Great technology, a comprehensive program, and a wonderful exhibit hall. This conference is a great place to do business.” — Jon Rowley, Rooster Bio

“The only one of its kind.” — Mahendra Rao, NYSCF

“This is a great event to keep abreast of the manufacturing advancements for the rapidly evolving cell and gene therapy industry.” — Brian Hampson, PCT, A Caladrius Company

Progress Toward Commercial Scale and Efficiency in Cell Therapy Bioprocessing

Cell and gene therapy is an extremely promising and growing medical technology sector with 631 ongoing clinical trials at the end of 2015. It is applicable to oncology, cardiovascular disease, infectious diseases and other diseases. The merit of cell and gene therapy has been demonstrated by FDA approvals, however commercialisation can prove a high hurdle that can trip up even approved therapeutics such as Dendreon’s Provenge autologous cell therapy. There are however steps that can be taken to reduce the risk associated with commercialisation that companies with a cell and gene therapy portfolio should consider. This whitepaper discusses practical measures to improve the chances of commercial success:

  • Characterization and Comparability Risk reduction through Quality by Design (QbD)
  • Improving efficiency and reducing costs in development and production
  • Novel analytical technologies and methodologies
  • Ensuring successful process scale up and transfer
  • Progress towards the industrialization of cell and gene therapies through modularisation

Plan Your Visit

Boston is a bustling city, but you can cover the center on foot in just a couple of hours. With the history of the Freedom Trail, the modern attractions of the Institute of Contemporary Art and everything in between, Boston is worth exploring for a weekend. For information on the venue, official conference hotel details, transportation, and more click here.

Networking Reception Co-Sponsor